Tag: pregnancy
-
New Medical Study About SSRI Antidepressants Used During Pregnancy And Autism Spectrum Disorder (ASD) In Children
JAMA Pediatrics Article Reports Increased Risk Is Greatest When These Depression Medicines Are Used By Mothers During The Second And/Or Third Trimester (Posted by Tom Lamb at DrugInjuryWatch.com) Some popular medications prescribed…
-
European Medicines Agency (EMA) Committee Recommends Further Restrictions On Use Of Depakote / Depakene / Depacon By Women Of Childbearing Age
Cites Higher Risks Of Neural Tube Defects Like Spina Bifida, Hypospadias, And Other Birth Defects As Well As Increased Risk Of Autism Spectrum Disorder (Posted by Tom Lamb at DrugInjuryWatch.com)More restrictions of the use of valproate drugs…
-
Significantly Increased Risk Of Autism Spectrum Disorder (ASD) In Children Whose Mothers Used Depacon / Depakene / Depakote During Their Pregnancy
August 2014 Label Change By AbbVie Inc. (formerly Abbott) For These Valproate Migraine, Epilepsy/Seizure, And Bipolar Medications Was Done Rather Quietly (Posted by Tom Lamb at DrugInjuryWatch.com)Without much notice, e.g., no FDA Drug Safety Communication was issued,…
-
Depakote Or Depakene Taken During Pregnancy May Cause Congenital Malformations Or Birth Defects Such As Neural Tube Defects Like Spina Bifida
In Addition, There Are FDA Warnings That Using Depakote Or Depakene While Pregnant May Put Child At Risk For Having A Lower IQ Score Later In Life (Posted by Tom Lamb at DrugInjuryWatch.com) Depakote…
-
FDA Seeks Information About Topamax-Related Oral Cleft Birth Defect Cases
Request For Historical Incidence Data Made In Connection With NDA For New Obesity Drug (Posted by Tom Lamb at DrugInjuryWatch.com)In mid-January 2011 the biopharmaceutical company Vivus, Inc. — while providing a regulatory update on…